MustGrow Biologics Corp.
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026
Revenue % change YoY	CA$12.86K N/A	CA$6.47K -49.65%	CA$4.71M 72630.35%	Avg: CA$25.43M Low: CA$25.43M High: CA$25.43M avg. 439.79%	Avg: CA$34.80M Low: CA$34.80M High: CA$34.80M avg. 36.82%
Net Income % change YoY	CA$-3.11M N/A	CA$-5.54M -77.75%	CA$-676.94K 87.78%	Avg: CA$17.96M Low: CA$17.96M High: CA$17.96M avg. 2753.42%	Avg: CA$20.95M Low: CA$20.95M High: CA$20.95M avg. 16.66%
EBITDA % change YoY	CA$-3.01M N/A	CA$-5.58M -85.36%	CA$-676.94K 87.87%	Avg: CA$-640.61K Low: CA$-640.61K High: CA$-640.61K avg. 5.36%	Avg: CA$-876.54K Low: CA$-876.54K High: CA$-876.54K avg. -36.82%
EPS % change YoY	-$0.07 N/A	-$0.11 -54.27%	-$0.01 87.63%	Avg: $0.36 Low: $0.36 High: $0.36 avg. 2747.05%	Avg: $0.42 Low: $0.42 High: $0.42 avg. 16.66%
Operating Expenses % change YoY	CA$3.02M N/A	CA$5.69M 88.21%	CA$4.53M -20.26%	Avg: CA$5.12B Low: CA$5.12B High: CA$5.12B avg. 112794.59%	Avg: CA$7.01B Low: CA$7.01B High: CA$7.01B avg. 36.82%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 1385.04% in 2025-2026.

We have gathered data from N/A analysts. Their low estimate is 17.96M, average is 17.96M and high is 17.96M.

Wall Street analysts forecast annual average revenue growth of 238.31% in 2025-2026.

We have gathered data from N/A analysts. Their low revenue estimate is CA$25.43M, average is CA$25.43M and high is CA$25.43M.

Wall Street analysts forecast annual average earnings growth of 1381.86% in 2025-2026.

We have gathered data from N/A analysts. Their low earnings per share estimate is $0.36, average is $0.36 and high is CA$0.36.